Innovation with a Practical Purpose

Innovation That Strengthens Pharmaceutical Capability.

For Jean Vichar, innovation means applying technology, process knowledge and partnership models to move valuable pharmaceutical products toward reliable commercial supply.

REF. JV-INNOV-001OUR APPROACH

Useful innovation solves a technical, commercial or healthcare problem.

Innovation is not a slogan or a separate department. It is the disciplined work of improving how products are developed, transferred, manufactured and supplied.

Jean Vichar focuses on opportunities where new capabilities or better coordination can create practical value: establishing manufacturing platforms, transferring products into local production, improving processes, supporting specialized drug-delivery technologies and connecting international pharmaceutical partners with domestic execution.

Every opportunity begins with evidence. The product need, technical feasibility, intellectual-property position, regulatory pathway, component availability, market context and manufacturing fit must be understood before resources are committed.

REF. JV-FOCUS-002WHERE INNOVATION HAPPENS

01 / PRODUCT

Formulation and product adaptation

Evaluating how an existing or new product can be formulated, transferred or adapted for the intended dosage form, market and manufacturing environment.

02 / PROCESS

Process development and optimization

Understanding material and process behavior, defining operating ranges and improving repeatability, efficiency and manufacturability.

03 / PLATFORM

Drug-delivery technologies

Building capability across oral solid dosage, metered-dose inhalers, nasal sprays and, through Lirok Pharma, dry powder inhalers.

04 / PARTNERSHIP

Technology transfer and localization

Working with product owners, API manufacturers and technology partners to translate established knowledge into controlled local manufacture.

05 / QUALITY

Data, documentation and control

Strengthening the systems that make technical decisions traceable and allow processes to be reviewed, validated and improved.

06 / ECOSYSTEM

Connected commercialization

Using the group’s sourcing, manufacturing, inhalation and distribution capabilities to reduce fragmented handoffs across the product lifecycle.

REF. JV-EVAL-003OPPORTUNITY EVALUATION

Good ideas progress through a structured review.

A project must make sense technically, operationally and commercially before it becomes a development program.

01

Define the need

Clarify the patient, market or supply problem and the benefit the proposed product or technology is expected to provide.

02

Assess product fit

Review formulation status, dosage form, API and component requirements, available data, regulatory pathway and manufacturing compatibility.

03

Build the development plan

Define technical work, responsibilities, decision gates, documentation, scale-up requirements, risk controls and expected outcomes.

04

Prepare for commercialization

Connect development activity to validation, registration support, supply planning, packaging and distribution rather than treating R&D as an isolated endpoint.

Partner-led opportunitiesWe evaluate APIs, dossiers, formulations and technologies proposed by external partners.
Manufacturing-led improvementOperational experience is used to improve process understanding, reliability and efficiency.
Market-linked developmentProjects are considered in relation to real healthcare, supply and commercialization needs.

REF. JV-COLLAB-004COLLABORATION

Innovation is stronger when knowledge moves in both directions.

Jean Vichar welcomes structured collaboration with API manufacturers, pharmaceutical companies, formulation specialists, technology owners and device or packaging partners.

A productive collaboration begins with clear information and realistic expectations. We assess what knowledge already exists, what must be generated, what the partner will provide and what Jean Vichar must establish locally. Confidentiality, intellectual-property responsibilities, development ownership and commercialization objectives should be addressed early.

Where the opportunity aligns with our platforms and strategy, collaboration can extend from feasibility and formulation through technology transfer, validation, registration support, commercial manufacturing and lifecycle management.